Paradoxical Effect of Freund's Complete Adjuvant upon Transplantation Efficiency
of Adenovirus-induced Tumour Cells (Accepted 20 May 1969) Adjuvants appear to act by creating a depot from which antigen is slowly released and by stimulating antibody-forming cells (Ehrich etal. I945 ). Freund's adjuvant consists of an emulsion of water in paraffin oil stabilized by lanolin derivatives (Freund, 194o) . Its action is potentiated byadding dead mycobacteria or mycobacterial lipid (complete adjuvant) and Freund attributes the cellular response to the mycobacterial substance (Freund, I956 ). Freund's complete adjuvant (FCA) can produce delayed hypersensitivity of extreme severity to a foreign antigen and at times sensitize an animal to its own tissue (Freund, Thompson & Lipton, I955 ) (auto-immunity). Transplantation and tumour immunity are chiefly of the cellular type (delayed hypersensitivity) and FCA appears to be an ideal agent to enhance such immunity. However, we observed increased tumour growth when hamsters were treated with FCA before challenge with adenovirus tumour cells. The present report describes this paradoxical enhancing effect.
Random-bred female Golden Syrian hamsters 3-4 weeks of age were obtained from Lakeview Farms, Newfield, N.J. Adenovirus type IZ transformed hamster cells furnished by Dr Aaron Freeman (Microbiological Associates, Inc.) were grown in 32 oz bottles containing Eagle's minimal essential medium (MEM) without calcium, to which a 1% solution of L-glutamine and a 0"2 °//o solution of vitamins and nonessential amino acids were added. Penicillin too u./ml., streptomycin IOO #g./ml. and kanamycin 5o/zg./ml. were included as well as IO % heat-inactivated foetal calf serum. The cells were allowed to grow until about 8o % confluent. The growth medium was then discarded, the cell layer washed twice with xo ml. of MEM and scraped into 5 ml. of MEM. The cells were counted in a haemocytometer and adjusted to the desired count with 85 to 9 ° % viability as determined by trypan-blue exclusion. Seventy-two hamsters were divided into three groups of 24; one group received IO, the second group lO 5 and the third group to e cells in o'5 ml. of MEM. All injections were subcutaneous. Half of the animals in each group were given o-2 ml. of FCA* intraperitoneally I7 days before tumour cell challenge; the other half were not pre-treated.
All (Fig. I) .
FCA has been reported to increase the incidence of tumours as well as the number of metastases in young chickens treated with small doses of Rous sarcoma virus (Rauscher, Fink & Kvedar, 1963) . Emulsions of FCA with polyoma virus and Rous * Arlacel A (mannide mono-oleate) 1.5 ml.; Bayol F (paraffin oil) 8"5 ml; Mycobacterium butyricum (killed and dried) 5 rag. 35-z sarcoma virus administered to newborn mice and rats also stimulated oncogenesis x968) . Goldner, Girardi and Hilleman (I965) reported that newborn hamsters inoculated with SV4o followed by the administration of Freund's incomplete adjuvant in the latent period increased tumour development. However, oncogenesis was reduced in hamsters treated neonatally and up to I week of age with adenovirus type I2 and FCA (Berman, Allison & Pereira, I967) . Under the conditions of this experiment, pretreatment with FCA apparently enhanced tumour formation in hamsters challenged with adenovirus type 12 tumour cells. General stimulation of the lymphoreticular system by non-specific materials has been utilized as a means of increasing resistance to tumours (Stjernsw/ird, 1966) . Our results suggest that such a stimulation might produce serious disadvantages to subjects so treated.
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